Quantcast

Latest Amgen Stories

2015-01-29 16:28:34

FIND FH Initiative Unites Industry, Advocacy Community and Academia in an Effort to Support People Affected by Familial Hypercholesterolemia (FH), a Serious Genetic Disorder THOUSAND OAKS,

2015-01-27 16:27:46

US Submission Designed to Support Conversion From Accelerated to Full FDA Approval and Expansion of Current Approved Indication THOUSAND OAKS, Calif.

2015-01-22 16:25:11

THOUSAND OAKS, Calif., Jan. 22, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its fourth quarter and full year 2014 financial results on Tuesday, Jan.

2015-01-21 08:29:21

-- First biosimilar from Samsung Bioepis to advance to EMA regulatory review -- INCHEON, South Korea, Jan.

2015-01-15 16:25:00

Exploratory Analysis of Phase 2 Trial Shows Earlier and Sustained Responses in Patients Treated With Vectibix Versus Bevacizumab THOUSAND OAKS, Calif., Jan.

2015-01-15 12:28:15

PORTLAND, Oregon, January 15, 2015 /PRNewswire/ -- A new report by Allied Market Research titled, "Global Erythropoietin (EPO) Drugs Market (Type, Application and Geography)

2015-01-12 16:24:09

MD Anderson's Moon Shots Program key to Collaboration THOUSAND OAKS, Calif. and HOUSTON, Jan.

2015-01-08 16:27:04

THOUSAND OAKS, Calif., Jan. 8, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the 33(rd) Annual J.P. Morgan Healthcare Conference at 9:30 a.m. PT on Tuesday, Jan.

2015-01-05 08:31:49

Alliance Combines Amgen's Oncology Targets and Kite's Leading CAR T Cell Therapy Platform to Develop new Therapeutic Candidates THOUSAND OAKS, Calif.


Word of the Day
deuteragonist
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.
Related